Both options are HSA and FSA eligible, making them accessible even if you're self-insured
Adults (18 years) with overweight or obesity BMI 30 kg/m2 *OR* BMI 27 kg/m2 with 1 weight-related comorbidity (hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease) This trial was for patients without type 2 diabetes Objective of the 2 year trial: To compare the 2-year effect of semaglutide 2.4 mg once weekly, vs placebo, on body weight, cardiovascular risk factors, and glucose metabolism
A report by the Institute for Clinical and Economic Review (ICER) found that although weight-loss drugs provide a net health benefit compared to lifestyle modification alone, the cost of drugs like Wegovy would need to decrease substantially (44-57%) to be considered cost-effective
It interacts with multiple systems in the body including the nitric oxide (NO) pathway, growth hormone receptors, and angiogenic regulators like VEGF (vascular endothelial growth factor) to promote tissue repair, reduce oxidative stress, and modulate the immune response
This article is for educational purposes only and does not replace professional medical advice